Bleichroeder LP’s ImmuCell ICCC Stock Holding History

Bleichroeder LP’s Portfolio ICCC Stock Details ICCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$503K	Sell	50,000 -51,594	-51%	-$456K	0.09%	52
2026 Q1	$643K	Hold	101,594	–	–	0.11%	47
2025 Q4	$625K	Hold	101,594	–	–	0.11%	40
2025 Q3	$635K	Hold	101,594	–	–	0.12%	42
2025 Q2	$707K	Hold	101,594	–	–	0.17%	36
2025 Q1	$487K	Hold	101,594	–	–	0.13%	42
2024 Q4	$523K	Hold	101,594	–	–	0.13%	37
2024 Q3	$369K	Hold	101,594	–	–	0.1%	44
2024 Q2	$493K	Hold	101,594	–	–	0.15%	39
2024 Q1	$538K	Hold	101,594	–	–	0.13%	40
2023 Q4	$517K	Hold	101,594	–	–	0.11%	34
2023 Q3	$543K	Hold	101,594	–	–	0.13%	31
2023 Q2	$508K	Hold	101,594	–	–	0.1%	42
2023 Q1	$524K	Hold	101,594	–	–	0.11%	35
2022 Q4	$620K	Hold	101,594	–	–	0.13%	36
2022 Q3	$760K	Hold	101,594	–	–	0.16%	38
2022 Q2	$883K	Buy	101,594 +30,521	+43%	+$265K	0.18%	40
2022 Q1	$686K	Buy	71,073 +8,824	+14%	+$76.1K	0.12%	55
2021 Q4	$498K	Buy	62,249 +1,642	+3%	+$14.7K	0.08%	67
2021 Q3	$567K	Hold	60,607	–	–	0.09%	62
2021 Q2	$576K	Buy	+60,607	New	+$591K	0.09%	59

Other funds holding ICCC

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Steadtrust Allen, Texas $198M AUM 99.37% 1-Year Est. Return

MFIM

Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Bleichroeder LP's ICCC Position: Q2 2026 in Review

Bleichroeder LP reduced its ImmuCell (ICCC) stake by 51% in Q2 2026, selling an estimated $456K and leaving 50,000 shares worth $503K. The position accounts for 0.09% of the portfolio, ranked #52.

Bleichroeder LP first reported a position in ICCC in Q2 2021 and has held it in 21 quarters since. The position peaked at $883K in Q2 2022. 31 funds tracked by Wall St. Rank hold ICCC as of Q2 2026.

Bleichroeder LP held 50,000 shares of ImmuCell worth $503K as of Q2 2026.
Bleichroeder LP sold 51,594 ImmuCell shares in Q2 2026, an estimated $456K.
ImmuCell made up 0.09% of Bleichroeder LP's portfolio in Q2 2026, its #52 holding.
Bleichroeder LP first reported a position in ImmuCell in Q2 2021 and has held it in 21 quarters since.
Bleichroeder LP's ImmuCell position peaked at $883K in Q2 2022.
31 funds tracked by Wall St. Rank held ImmuCell as of Q2 2026.

Based on Bleichroeder LP's 13F filing for Q2 2026, filed 13 Aug 2026.